Study of a new nerve stimulation device for chronic cluster headache prevention
Part of Brain & nervous system clinical trials.
This study is testing a new device that uses mild electrical stimulation near the back of the head to prevent cluster headaches. It is for people with chronic cluster headaches that are hard to treat with standard medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 22 and 70 years old.
- You have a diagnosis of chronic cluster headache for at least 1 year.
- You have at least 4 headache attacks per week on average.
- You have a history of trying at least one preventive treatment that did not work well or caused side effects (e.g., verapamil, lithium, topiramate, or local injections).
- You have been on a stable headache medication regimen (or no preventive treatment) for at least 2 weeks before starting the study.
- You are able to fill out an electronic headache diary and attend study visits.
- You do not have other serious medical conditions that could interfere with the study (such as epilepsy, stroke, or substance use disorder).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a device that stimulates nerves on your face and the back of your head can prevent chronic cluster headaches. It may offer a new treatment option if you have had cluster headaches for at least a year.
This Phase 3 trial tests whether repeated injections can reduce attacks of chronic cluster headache. It may help people who have frequent, consistent attacks and can track them closely during the study.
This trial studies whether stimulating a nerve in the back of the head can reduce chronic cluster-like or related headache attacks. It’s for people whose headaches did not improve after trying several standard prevention treatments.
This trial tests a treatment called occipital nerve stimulation, which uses a device to send gentle electric pulses to nerves at the back of your head. The goal is to see if it can help people who have not found relief from other migraine treatments.
This trial tests whether injections of botulinum toxin type A can reduce frequent, severe cluster headache attacks by targeting a facial nerve area. It’s for people whose cluster headaches have not responded well—or have caused side effects—to standard preventive treatments.
This trial studies a temporary nerve-stimulation device placed near the back of your head to treat chronic headaches. The device sends mild electrical pulses to help reduce headache pain over 60 days, and your doctor has already decided this treatment is right for you as part of your regular care.
Hear when a new Chronic Cluster Headache trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.